Gene · 4605
Papers2,561
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,561
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KIF18B Is Essential for Lung Adenocarcinoma Progression Through the E2F Transcriptional Network. | Int J Mol Sci | 2026 | 41751942 | PubTator, text mining | PubMed |
| Effect of Quinoa Germ Meal as a Replacement for Fish Meal in Diets on Intestinal Health of Juvenile Turbot (Scophthalmus maximus). | Biology (Basel) | 2026 | 41744613 | PubTator, text mining | PubMed |
| Actin-related protein 6 regulates the Hedgehog signaling pathway: Molecular basis for stemness maintenance of hepatoma cells. | Cytojournal | 2026 | 41743751 | PubTator, text mining | PubMed |
| Deoxylapachol inhibits esophageal squamous cell carcinoma progression via targeting FOXM1-mediated Wnt/β-catenin pathway. | Phytomedicine | 2026 | 41734711 | PubTator, text mining | PubMed |
| Biomimetic 3D-Bioprinted organoids of thymic epithelial tumors for translational drug screening and biomarker identification. | Mater Today Bio | 2026 | 41732385 | PubTator, text mining | PubMed |
| NK cell-associated LncRNA signature predicts prognosis and immune landscape in hepatocellular carcinoma. | Clin Exp Med | 2026 | 41731179 | PubTator, text mining | PubMed |
| The Role of PDE3A in Cancer. | ACS Omega | 2026 | 41726589 | PubTator, text mining | PubMed |
| Editorial: New insights into gut microbiota in colorectal cancer. | Front Cell Infect Microbiol | 2026 | 41716463 | PubTator, text mining | PubMed |
| FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. | Cell Death Dis | 2026 | 41714589 | PubTator, text mining | PubMed |
| Integrative bulk and single-cell transcriptomics link EZH2 to immunosuppressive programs and tumor-Treg crosstalk in castration-resistant prostate cancer. | Front Immunol | 2026 | 41710887 | PubTator, text mining | PubMed |
| Single-Cell RNAseq Identifies Heterogeneity in Myoblasts From Older Adults With Differences Related to Muscle Mass and Function. | J Cachexia Sarcopenia Muscle | 2026 | 41703779 | PubTator, text mining | PubMed |
| Tumor cell cycle regulation: integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies. | Mol Biomed | 2026 | 41692895 | PubTator, text mining | PubMed |
| Metabolic Adaptation and Pulmonary ceRNA Network Plasticity in Orientallactaga sibirica During Water Deprivation Stress. | Int J Mol Sci | 2026 | 41683882 | PubTator, text mining | PubMed |
| 7,7"-dimethoxyagastisflavone induced MYCN/MYBL2-dependent apoptosis and metabolism reprogramming in Sonic Hedgehog medulloblastoma. | J Transl Med | 2026 | 41680840 | PubTator, text mining | PubMed |
| SUMOylation of UBE2C facilitates hepatocellular carcinoma proliferation and invasion via the MAPK pathway. | Transl Cancer Res | 2026 | 41674974 | PubTator, text mining | PubMed |
| SPP1+ Macrophage-POSTN+ Fibroblast-Endothelial Triad Dictates Immunotherapy Response in Bladder Cancer. | FASEB J | 2026 | 41653034 | PubTator, text mining | PubMed |
| NFATc3 Enhances DREAM Complex-Driven Transactivation. | bioRxiv | 2026 | 41648269 | PubTator, text mining | PubMed |
| Extrachromosomal DNA drives molecular and clinical heterogeneity in hepatocellular carcinoma: a multi-omics analysis and prognostic model development. | Hum Genomics | 2026 | 41634868 | PubTator, text mining | PubMed |
| Exploring the mechanism and therapeutic potential of BUB1 in regulating esophageal cancer progression based on 5-FU target prediction. | Discov Oncol | 2026 | 41618008 | PubTator, text mining | PubMed |
| Polyhydroxyalkanoate Microspheres Promote Skin Regeneration by Activating the MYBL2 Transcription Factor. | Adv Healthc Mater | 2026 | 41612595 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4605/papers?page=3